Insulin Lispro: all 130 studies that test it

Page 1 of 2. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.

• Perioperative Glucose Monitoring and Treatment to Reduce Risk of Surgical Site Infections and ComplicationsEnrolling by invitationNCT06765655Not applicable
• Mealtime or Post-meal Dosing of URLi in Medtronic 780G Hybrid Closed Loop SystemNot yet recruitingNCT06600776Phase 4
• A Trial of Three- and Seven-days Insulin Infusions SetRecruitingNCT06532461Not applicable
• Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro (ACOLYTE Study)RecruitingNCT05660941Not applicable
• A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in IndiaCompletedNCT06370715Phase 4Results posted
• A Study of LY8888AX in Participants Using a Connected Insulin Management PlatformCompletedNCT05893797Not applicableResults posted
• Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 DiabetesCompletedNCT05508061Not applicableResults posted
• A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 DiabetesCompletedNCT05262387Phase 1Results posted
• A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)CompletedNCT04605991Phase 3Results posted
• A Study of LY900014 and Insulin Degludec in Participants With Type 1 DiabetesCompletedNCT04585776Phase 2Results posted
• A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin PumpsCompletedNCT04276207Phase 1Results posted
• A Study of LY900014 in Healthy Chinese ParticipantsCompletedNCT04049123Phase 1Results posted
• A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 DiabetesCompletedNCT03952143Phase 3Results posted
• A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 DiabetesCompletedNCT03952130Phase 3Results posted
• A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump TherapyCompletedNCT03830281Phase 3Results posted
• A Study of LY900014 in a Medtronic PumpCompletedNCT03760640Phase 2Results posted
• A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 DiabetesCompletedNCT03740919Phase 3Results posted
• Remission Through Early Monitored Insulin Therapy - Duration MonthCompletedNCT03670641Phase 4Results posted
• A Study of Continuous Subcutaneous Insulin Infusion (CSII) Pump Function in Subjects With Type 1 Diabetes With Recombinant Human Hyaluronidase (rHuPH20)CompletedNCT03662334Phase 4Results posted
• Study to Compare 2 Formulations of LY900014 in Healthy ParticipantsCompletedNCT03616977Phase 1Results posted
• A Study of LY900014 in Participants With Type 1 Diabetes MellitusCompletedNCT03465878Phase 1Results posted
• A Meal Test Study of LY900014 in Participants With Type 1 Diabetes MellitusCompletedNCT03449433Phase 1Results posted
• A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 DiabetesCompletedNCT03433677Phase 3Results posted
• A Study of LY900014 in Japanese Participants With Type 1 Diabetes MellitusCompletedNCT03407118Phase 1Results posted
• A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)CompletedNCT03341312Phase 1Results posted
• A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes MellitusCompletedNCT03341299Phase 1Results posted
• A Study to Compare 2 Formulations of LY900014 in Healthy ParticipantsCompletedNCT03334448Phase 1Results posted
• A Study of LY900014 in Participants With Type 2 Diabetes MellitusCompletedNCT03305822Phase 1Results posted
• A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy ParticipantsCompletedNCT03286751Phase 1Results posted
• Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic PancreasTerminatedNCT03262116Phase 2/3Results posted
• A Study of LY900014 Formulation at Different Injection Sites in Healthy ParticipantsCompletedNCT03232983Phase 1Results posted
• A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 DiabetesCompletedNCT03214380Phase 3Results posted
• A Study of LY900014 in Participants With Type 1 DiabetesCompletedNCT03214367Phase 3Results posted
• A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes MellitusCompletedNCT03166124Phase 1Results posted
• A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin PumpCompletedNCT03056456Phase 1Results posted
• A Study of LY900014 Formulation in Healthy ParticipantsCompletedNCT02942654Phase 1Results posted
• A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese ParticipantsCompletedNCT02770521Phase 1Results posted
• A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy ParticipantsCompletedNCT02752087Phase 1Results posted
• A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection TherapyCompletedNCT02703350Phase 1Results posted
• A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection TherapyCompletedNCT02703337Phase 1Results posted
• A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin PumpsCompletedNCT02703324Phase 1Results posted
• A Study of Various Formulations of LY900014 in Healthy ParticipantsCompletedNCT02636361Phase 1Results posted
• A Study of a New LY900014 Formulation in Healthy ParticipantsCompletedNCT02525744Phase 1Results posted
• A Study of LY900014 Formulations in Healthy ParticipantsCompletedNCT02317575Phase 1Results posted
• A Study of Lispro Formulations in Healthy ParticipantsCompletedNCT02293551Phase 1Results posted
• Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes MellitusCompletedNCT02229227Phase 3Results posted
• A Study of 2 Different Formulations of Insulin Lispro in Healthy ParticipantsCompletedNCT02111083Phase 1Results posted
• Effect of Apidra Compared to Humalog in Decreasing Post-Prandial HyperglycemiaCompletedNCT01621776Not applicableResults posted
• Humalog® Mix50/50(tm) as a Treatment for Gestational DiabetesCompletedNCT01613807Phase 4Results posted
• Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump TherapyCompletedNCT01474538Phase 3Results posted
• Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 DiabetesCompletedNCT01215955Phase 4Results posted
• A Study of Postprandial Hyperglycemia in Participants With Type 2 DiabetesCompletedNCT01159938Phase 4Results posted
• Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular InsulinTerminatedNCT01136746Phase 3Results posted
• Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump UseCompletedNCT01134107Phase 3Results posted
• Bioequivalence of Two Lispro FormulationsCompletedNCT01133392Phase 1Results posted
• Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump UseCompletedNCT01109316Phase 3Results posted
• A Study of Insulin Lispro Mix in Type 2 Diabetic Asian PatientsCompletedNCT00971997Phase 4Results posted
• Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type 2 Diabetes Mellitus (T2DM)CompletedNCT00916357Phase 2Results posted
• Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes MellitusCompletedNCT00883558Phase 2Results posted
• Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro AloneCompletedNCT00862849Phase 1Results posted
• Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes MellitusCompletedNCT00774800Phase 2Results posted
• Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20CompletedNCT00705536Phase 1Results posted
• Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-WeeksTerminatedNCT00700622Phase 3Results posted
• A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes PatientsCompletedNCT00666718Phase 3Results posted
• Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light BreakfastCompletedNCT00664534Phase 4Results posted
• Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes MellitusCompletedNCT00607087Phase 4Results posted
• Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and ExenatideCompletedNCT00560417Phase 3Results posted
• A Study for Type 2 Diabetic PatientsCompletedNCT00548808Phase 4Results posted
• Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE)CompletedNCT00510952Phase 3Results posted
• Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)CompletedNCT00494013Phase 3Results posted
• Comparison of Two Basal Insulin Therapies for Patients With Type 1 DiabetesCompletedNCT00487240Phase 3Results posted
• Comparison of Insulins Aspart and Lispro in Insulin PumpsCompletedNCT00461331Phase 4Results posted
• Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump TherapyTerminatedNCT00428207Not applicableResults posted
• A Study for Patients With Diabetes Mellitus (IOPA)CompletedNCT00420095Phase 4Results posted
• Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)CompletedNCT00393705Phase 4Results posted
• Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)CompletedNCT00377858Phase 4Results posted
• Hyperglycemia and Cardiovascular Outcomes With Type 2 DiabetesCompletedNCT00191282Phase 4Results posted
• A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)CompletedNCT06280703Phase 1
• Is Brain Insulin Resistance a Feature of the Biology of Depression in AdolescentsCompletedNCT05571878Not applicable
• Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and ProteinCompletedNCT04783376Phase 4
• The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.CompletedNCT04124302Phase 4
• Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index MealCompletedNCT04019821Phase 4
• A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 DiabetesCompletedNCT03890003Not applicable
• A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes MellitusCompletedNCT03849612Not applicable
• A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal ChallengesCompletedNCT03848767Not applicable
• A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)CompletedNCT03743285Not applicable
• Azithromycin Insulin Diet Intervention Trial in Type 1 DiabetesStatus unknownNCT03682640Phase 2
• A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro to Humalog® in Healthy SubjectsCompletedNCT03604575Not applicable
• Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 DiabetesCompletedNCT03509324Phase 4
• A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)CompletedNCT03367390Phase 1
• Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)CompletedNCT03328845Phase 4
• Dynamics of Insulin Absorption in Subclinical Lipohypertrophy Using the Euglycemic Clamp TechniqueWithdrawnNCT03229850Not applicable
• A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin PumpCompletedNCT03179332Phase 1
• Environmental Effects Type 1 Diabetes MellitusCompletedNCT03102476Not applicable
• Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.Status unknownNCT02685449Phase 4
• A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin PumpsWithdrawnNCT02623478Phase 1
• A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection TherapyWithdrawnNCT02623465Phase 1
• A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection TherapyWithdrawnNCT02623452Phase 1
• Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin InfusionCompletedNCT02603510Phase 1
• A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes MellitusCompletedNCT02562326Phase 1

← Insulin Lispro overview